Pancreatic Cancer Research

ResearcherRoyal Netherlands Academy of Arts and SciencesActive in the last 2 years

Hans C. Clevers

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-3077-5582; OpenAlex author ID A5062248785. Sources: OpenAlex.

Their work

Papers
10 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
55
Papers, trials and grants by year

2015: 1 paper · 2016: 3 papers · 2017: 1 paper · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: none · 2022: 2 papers · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 10

  1. WNT7B drives a program for pancreatic cancer subtype switching and progression. Co-author DOI 10.1016/j.isci.2026.115050↗
  2. Analysis of the glyco-code in pancreatic ductal adenocarcinoma identifies glycan-mediated immune regulatory circuits. Co-author DOI 10.1038/s42003-021-02934-0↗
  3. Loss of Rnf43 Accelerates Kras-Mediated Neoplasia and Remodels the Tumor Immune Microenvironment in Pancreatic Adenocarcinoma. Co-author DOI 10.1053/j.gastro.2021.12.273↗
  4. Pancreatic cancer organoids recapitulate disease and allow personalized drug screening. Last author DOI 10.1073/pnas.1911273116↗
  5. Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer. Co-author DOI 10.1158/2159-8290.cd-18-0349↗
  6. Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer. Co-author DOI 10.1084/jem.20162024↗
  7. Preclinical models of pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/path.4651↗
  8. Modeling pancreatic cancer with organoids. Co-author DOI 10.1016/j.trecan.2016.03.004↗
  9. Model organoids provide new research opportunities for ductal pancreatic cancer. Last author DOI 10.1080/23723556.2015.1014757↗
  10. Organoid models of human and mouse ductal pancreatic cancer. Co-author DOI 10.1016/j.cell.2014.12.021↗

Closest collaborators

The 25 strongest of 55 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Frederike Dijk · 2 shared papers, 2022–2026 · strength 0.39
  2. Lodewijk A.A. Brosens · 2 shared papers, 2019–2026 · strength 0.34
  3. David Arthur Tuveson · 5 shared papers, 2015–2017 · strength 0.32
  4. Joep Sprangers · 1 shared paper, 2026 · strength 0.27
  5. Madelon M. Maurice · 1 shared paper, 2026 · strength 0.27
  6. Sylvia F. Boj · 4 shared papers, 2015–2019 · strength 0.26
  7. Lindsey A. Baker · 4 shared papers, 2015–2017 · strength 0.24
  8. Chang‐Il Hwang · 4 shared papers, 2015–2017 · strength 0.24
  9. Else Driehuis · 2 shared papers, 2019–2022 · strength 0.19
  10. Hervé Tiriac · 3 shared papers, 2015–2017 · strength 0.17
  11. Dannielle D. Engle · 3 shared papers, 2015–2017 · strength 0.15
  12. Takashi Okumura · 1 shared paper, 2022 · strength 0.13
  13. Lotfi Abou‐Elkacem · 1 shared paper, 2022 · strength 0.13
  14. Jason Roszik · 1 shared paper, 2022 · strength 0.13
  15. Maria E. Monberg · 1 shared paper, 2022 · strength 0.13
  16. Paola A. Guerrero · 1 shared paper, 2022 · strength 0.13
  17. Mohamed Zaid · 1 shared paper, 2022 · strength 0.13
  18. Abdel Nasser Hosein · 1 shared paper, 2022 · strength 0.13
  19. Anirban Maitra · 1 shared paper, 2022 · strength 0.13
  20. Bidyut Ghosh · 1 shared paper, 2022 · strength 0.13
  21. Aatur Dilip Singhi · 1 shared paper, 2022 · strength 0.13
  22. Laura L. Meijer · 1 shared paper, 2022 · strength 0.12
  23. Yvette van Kooyk · 1 shared paper, 2022 · strength 0.12
  24. Manfred Wuhrer · 1 shared paper, 2022 · strength 0.12
  25. Kelly Boelaars · 1 shared paper, 2022 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.